Basic info
Industry
biotechnology research
Sectors
DNA vaccine
Neoantigens
Biotechnology
Neoepitopes
Immunotherapy
Oncology
Pharmaceutical
Clinical Trials
Immuno-oncology
HPV16
Date founded
2007
Funding rounds raised
Total raised
$25M
from 3 investors over 3 rounds
N
Nykode Therapeutics raised $25M on December 16, 2016
Investors: The Research Council of Norway
N
Nykode Therapeutics raised $966K on June 21, 2013
Investors: The Research Council of Norway
N
Nykode Therapeutics raised $2.6M on October 23, 2012
Investors: The Research Council of Norway